Mark Davison is CEO at Blue Sphere Health Ltd and the author of Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs and Pharmaceutical Serialisation: Opportunity or Perfect Storm.www.bluespherehealth.com
Applying Universal Anticounterfeiting Technologies
It is very difficult to measure the problem of counterfeiting accurately from year to year; by definition criminals don?t file tax returns or publish quarterly earnings.
Obstacles To Implementing An Effective Anti-Counterfeiting Strategy: Can They Be Overcome?
The effects of counterfeiting are hard to measure, both in human impact and financial loss.
Obstacles to implementing an effective anti-counterfeit strategy: can they be overcome?